Global Market Watch:
The Invasive Devices market is expected to reach US$10.4 billion by 2016 primarily supported by the segments Syringes, Pens, Pumps and Other. Globally, Syringes and Pumps together account for approximately more than 50% of the market and is expected that Insulin Delivery Devices industry to be going forward. Geographical analysis for Invasive Devices market shows that the highest Compounded Annual Growth Rate (CAGR) of 9.2% is anticipated from Asia-Pacific region during the analysis period, 2014-2021. Middle East follows Asia-Pacific with a CAGR of 8.6% while Africa forecasts to drive with a growth rate of 8.6%. As for Non-Invasive Devices the market is increasing at a Compound Annual Growth rate of 10.5% during the analysis period of 2014-2021.
The report “Insulin Delivery Devices - Global Trends, Estimates and Forecasts, 2014-2021” reviews the latest insulin market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:
- Emerging market trends
- Advancements in the technological space
- Market demand of the segments (by-region)
- Key growth areas and market size
- Key competitor’s Edge
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.
The analysis primarily deals with insulin delivery devices market segment. Further, the subdivided categories include:
Insulin Delivery Devices
1. Invasive Devices
i. Reusable Cartridges
ii. Disposable Cartridges
2. Non-Invasive Devices
d. Jet Injectors
* Other: Softaware of Pumps, Smart Caps, Walet, Syringer Holders, Spring-Loaded Syringe Holders, Syringe Magnifiers and Light, Pen Needles
The period considered for the insulin delivery devices market analysis is 2014-2021. The region wise distribution of the market consists of The Americas (USA, Brazil, Canada, Mexico, Argentina and Rest of The Americas), Europe (Germany, United Kingdom, France, Russia, Italy, Spain, The Netherlands and Rest of Europe), Asia- Pacific (China, Japan, India, South Korea, Australia and Rest of Asia-Pacific), Africa (South Africa, Nigeria, Kenya and Rest of Africa) and Middle East (Egypt, Turkey, UAE and Rest of Middle East). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.
More than 40 leading market players are identified and 20 key companies that project improved market activities in the near future are profiled. The report consists of 95 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.